vision

Open enrollment season is upon us, when employees can chose again from among the smorgasbord of benefit options offered by their employers. To help you ensure you're getting the most bang for your health care buck -- and not paying more than you need to -- we went to the experts for advice.

A popular eyelash-enhancing drug's promotional materials are raising eyebrows among federal regulators. The U.S. Food and Drug Administration has warned Allergan (AGN) about what the agency says is misleading information on its website for Latisse, a prescription cosmetic drug that lengthens,...